FDA Says Breast Cancer Drug Did Not Extend Lives

Federal health scientists said Friday that follow-up studies of a Roche breast cancer drug show it failed to slow tumor growth or extend patient lives, opening the door for a potential withdrawal in that indication.


Panel: Diabetes Drug Avandia To Stay On Shelves

A majority of federal health experts have voted to keep controversial diabetes pill Avandia on market, despite concerns that the drug increases the risk of heart attack compared to other diabetes medications.


Avandia Drug Trials Shut Down In India

CBS News has learned that the Indian government has ordered Glaxo Smith Kline to suspend 19 drug trials in India for the controversial diabetes drug Avandia because of recently released studies showing potential heart problems […]


FDA Spotlights Heart Risk Of Diabetes Pill

A review by federal health scientists reinforces potential ties between the diabetes pill Avandia and heart attack and death, opening the door for government action, including a possible withdrawal of the once blockbuster drug.